<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">JDM</journal-id><journal-title-group><journal-title>Journal of Diabetes Mellitus</journal-title></journal-title-group><issn pub-type="epub">2160-5831</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/jdm.2019.93012</article-id><article-id pub-id-type="publisher-id">JDM-94524</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Complementary and Alternative Medicine: A Review on the Effects of Ginger, Cinnamon and Camellia Sinensis Leaf Tea in Diabetes
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Massud</surname><given-names>Atta</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Shadi</surname><given-names>Jafari</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Kareen</surname><given-names>Moore</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib></contrib-group><aff id="aff1"><addr-line>Coliseum Medical Center, Macon, Georgia</addr-line></aff><aff id="aff2"><addr-line>American University of Antigua, COM, Coolidge, Antigua</addr-line></aff><pub-date pub-type="epub"><day>09</day><month>08</month><year>2019</year></pub-date><volume>09</volume><issue>03</issue><fpage>126</fpage><lpage>136</lpage><history><date date-type="received"><day>5,</day>	<month>June</month>	<year>2019</year></date><date date-type="rev-recd"><day>19,</day>	<month>August</month>	<year>2019</year>	</date><date date-type="accepted"><day>22,</day>	<month>August</month>	<year>2019</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Diabetes mellitus is a chronic disease with a multitude of effects on different organ-systems. Its chronic nature makes it a challenging disease for patients to manage. Today, patients have access to many different types of conventional therapies for diabetes, each with a different mode of action and side effects. Despite the wide range of therapeutic agents available today, patients seek help from complementary and alternative medicine. The decision to use complementary and alternative medicine by patients stems from some of the harmful side effects of current conventional therapies, as well as their desire to find measures that will help them to manage their disease. Complementary and alternative medicine includes several modalities ranging from dietary components such as vitamins and herbal supplements to mind-body interventions such as yoga, meditation, and massage therapy. Here we review the use of complementary and alternative medicine including Ginger, Cinnamon, and 
  <em>Camellia sinensis</em> leaf tea, and their effects on glycemic indices in diabetes.
 
</p></abstract><kwd-group><kwd>Diabetes Mellitus</kwd><kwd> Complementary and Alternative Medicine</kwd><kwd> Insulin</kwd><kwd> Hemoglobin A1c</kwd><kwd> Fasting Blood Glucose</kwd><kwd> Ginger</kwd><kwd> Cinnamon</kwd><kwd> Camellia Sinensis</kwd><kwd> &lt;i&gt;Zingiber officinale</kwd><kwd> Cinnamomum zeylanicum</kwd><kwd> Ceylon cinnamon</kwd><kwd> Cinnamon cassia&lt;/i&gt;</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Diabetes mellitus (DM) is a chronic disease that affects millions of people worldwide. The lack of production of insulin from the beta-islet cells of the pancreas results in Type 1 Diabetes (DM1), also called Juvenile Diabetes. The body’s inability to respond to insulin, known as insulin insensitivity, results in Type 2 Diabetes Mellitus (DM2). According to the World Health Organization (WHO), in 2014 8.5% of adults over the age of 18 suffer from DM, compared to 4.7% in 1980 [<xref ref-type="bibr" rid="scirp.94524-ref1">1</xref>] . In 2015, the International Diabetes Federation (IDF) recorded 415 million adults suffering from diabetes and estimated an increase to 642 million by 2040 [<xref ref-type="bibr" rid="scirp.94524-ref2">2</xref>] . According to the American Diabetes Association (ADA), diabetes is diagnosed by either Hemoglobin A1c (HbA1c) levels ≥ 6.5%, Fasting Blood Glucose (FBG) ≥ 126 mg/dL measured at 2 different times or a random blood glucose ≥ 200 mg/dL with symptoms of DM2 [<xref ref-type="bibr" rid="scirp.94524-ref3">3</xref>] .</p><p>Despite the advancements in diabetes treatment, many patients seek alternative options due to various reasons. Complementary and alternative medicine (CAM) has gained popularity because of the possibilities it offers to patients. Complementary medicine refers to the use of products in adjunction to conventional treatments, while alternative medicine is the use of products as a substitute for conventional medicine [<xref ref-type="bibr" rid="scirp.94524-ref4">4</xref>] . The National Center for Complementary and Integrative Health (NCCIH) defines CAM as “a group of medical and health care systems, practices and products that are not presently considered to be part of conventional medicine” [<xref ref-type="bibr" rid="scirp.94524-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.94524-ref5">5</xref>] .</p><p>A 2012 survey by the National Health Interview Survey (NHIS) reports the use of “dietary supplements other than vitamins and minerals” by 17.7% of Americans [<xref ref-type="bibr" rid="scirp.94524-ref4">4</xref>] . Diabetics compared to non-diabetics are 1.6 times more likely to try CAM and there are different contributing factors leading to this decision [<xref ref-type="bibr" rid="scirp.94524-ref6">6</xref>] . Medication side effects, cost of treatment, the ability to manage their illness, personal and cultural beliefs and disease progression despite the use of conventional medicines all play a role in why people choose CAM [<xref ref-type="bibr" rid="scirp.94524-ref2">2</xref>] . Dietary supplements such as vitamins, minerals, and herbal teas are amongst the common methods of CAM. There are also other types of CAM that focuses on mind-body health such as yoga, meditation, massage therapy, Tai Chi, acupuncture, music and art therapy [<xref ref-type="bibr" rid="scirp.94524-ref7">7</xref>] . In this paper, we focus on the following CAM and their role in the treatment of Diabetes: ginger, cinnamon and herbal tea.</p></sec><sec id="s2"><title>2. Ginger</title><p>Ginger (Zingiber officinale), originated in Southeast Asia, is one of the most widely consumed spices around the world [<xref ref-type="bibr" rid="scirp.94524-ref8">8</xref>] . It has long been used as herbal medicine to treat a variety of ailments including nausea, indigestion, and common cold symptoms. Recently, studies have suggested that the antioxidant properties of ginger can also exert anticancer, anti-inflammatory, and anti-hyperglycemic effects [<xref ref-type="bibr" rid="scirp.94524-ref9">9</xref>] . Studies on diabetic-induced rats both in vitro and in vivo have shown that aqueous extracts of Z. officinale and polyphenol compounds in ginger can affect carbohydrate and lipid metabolism as well as insulin sensitivity. The mechanism by which ginger can exert these anti-diabetic effects is hypothesized to occur through the inhibition of several transcriptional pathways, lipid peroxidation, carbohydrate-metabolizing enzymes, and the activation of antioxidant enzymes [<xref ref-type="bibr" rid="scirp.94524-ref10">10</xref>] .</p><p>Ginger is speculated to reduce serum glucose levels through the activities of phenols, polyphenols, and flavonoids, which may inhibit intestinal glucosidase and amylase enzymes [<xref ref-type="bibr" rid="scirp.94524-ref11">11</xref>] . The antioxidants within ginger, including paradol and zingerone, can counteract lipid peroxidation [<xref ref-type="bibr" rid="scirp.94524-ref12">12</xref>] [<xref ref-type="bibr" rid="scirp.94524-ref13">13</xref>] [<xref ref-type="bibr" rid="scirp.94524-ref14">14</xref>] . These antioxidants might also decrease insulin resistance by improving glucose transport through the upregulation of the GLUT-4 transporter and insulin receptors, and enhance the activity of pancreatic beta islet cells secretory function [<xref ref-type="bibr" rid="scirp.94524-ref15">15</xref>] [<xref ref-type="bibr" rid="scirp.94524-ref16">16</xref>] . Other properties of ginger, including 6-gingerol and 6-shogaol, were found to increase insulin sensitivity by upregulating adiponectin and PPARγ [<xref ref-type="bibr" rid="scirp.94524-ref17">17</xref>] .</p><p>Furthermore, studies conducted in streptozocin (STZ)-induced diabetic rats have been used to review the effects of ginger in diabetes. One study evaluated the anti-hyperglycemic effect of aqueous extract of 500 mg/kg ginger administered orally on a daily basis to rats in three different doses (100, 300, 500 mg/kg) for a period of 30 days. Results revealed a “dose-dependent anti-hyperglycemic effect with a decrease in plasma glucose levels by 38% and 68% on the 15<sup>th</sup> and 30<sup>th</sup> day, respectively” [<xref ref-type="bibr" rid="scirp.94524-ref18">18</xref>] . In another study, an aqueous extract of 500 mg/kg raw ginger was administered intraperitoneally daily to rats for a period of 7 weeks. The raw ginger was effective in lowering serum glucose, cholesterol and triacylglycerol levels in the ginger-treated diabetic rats compared with the control diabetic rats. The ginger treatment also resulted in a reduction in urine protein levels [<xref ref-type="bibr" rid="scirp.94524-ref19">19</xref>] . These studies suggest a direct effect of ginger and gingerols in the treatment of diabetes. However, further studies are needed to evaluate its safety uses and to clearly establish what dosage provides the greatest efficacy for the treatment of diabetes.</p></sec><sec id="s3"><title>3. Cinnamon</title><p>Cinnamon, also called sweet wood (Greek origin), is obtained from the inner bark of a tropical evergreen tree [<xref ref-type="bibr" rid="scirp.94524-ref6">6</xref>] . Cinnamon has long been used in Indian Ayurvedic medicine, Unani System as well as 19th century American medicine to treat a variety of disorders [<xref ref-type="bibr" rid="scirp.94524-ref20">20</xref>] . The plant with over 250 species has two main varieties: Cinnamomum zeylanicum (CZ) or true/Ceylon cinnamon and Cinnamon cassia (CC) also known as Cinnamomum aromaticum/Chinese cinnamon [<xref ref-type="bibr" rid="scirp.94524-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.94524-ref20">20</xref>] [<xref ref-type="bibr" rid="scirp.94524-ref21">21</xref>] [<xref ref-type="bibr" rid="scirp.94524-ref22">22</xref>] . Cinnamon can be purchased in its quill form (cinnamon sticks), ground cinnamon powder, and aqueous extract. It contains constituents including; Cinnamaldehyde, Cinnamic acid, Cinnamyl acetate and eugenol which contribute to the therapeutic properties of cinnamon [<xref ref-type="bibr" rid="scirp.94524-ref23">23</xref>] .</p><p>One main area of interest to researchers has been the effect of cinnamon in diabetes and its role in decreasing blood sugar levels. Cinnamon is thought to lower blood sugar by 1) Enhancing the activity of insulin receptor through autophosphorylation, 2) Promoting glucose uptake by enhancing the expression of GLUT-4, 3) Stimulating glycogenesis, 4) Inhibiting gluconeogenesis, and 5) Inhibiting the activity of enzymes such as pancreatic alpha-amylase and alpha-glucosidase [<xref ref-type="bibr" rid="scirp.94524-ref21">21</xref>] [<xref ref-type="bibr" rid="scirp.94524-ref24">24</xref>] . GLUT-4, a family of transmembrane proteins involved in the uptake of glucose, is under the regulation of insulin. Insulin binds to insulin receptor (IR) which causes autophosphorylation of tyrosine residues on β-subunit of the receptor. This further activates a phosphatidylinositol 3 kinase signaling cascade that leads to expression of GLUT-4 on the cell surface [<xref ref-type="bibr" rid="scirp.94524-ref22">22</xref>] [<xref ref-type="bibr" rid="scirp.94524-ref25">25</xref>] . Cinnamtannin B1 and Cinnamaldehyde act like insulin to induce the IR. [<xref ref-type="bibr" rid="scirp.94524-ref22">22</xref>] [<xref ref-type="bibr" rid="scirp.94524-ref25">25</xref>] . Different studies done by Anderson et al. and Cao et al. demonstrated that polyphenols extracted from cinnamon have displayed similar activity to insulin [<xref ref-type="bibr" rid="scirp.94524-ref23">23</xref>] .</p><p>The biomarkers used in these studies are fasting plasma glucose (FPG) and HbA1c. A study done by Khan et al. showed reduction in FPG, although no effect was observed on lowering HbA1c [<xref ref-type="bibr" rid="scirp.94524-ref20">20</xref>] . Similarly, a double-blind clinical trial study done by Mang et al. showed reduction in FPG and no effect on lowering HbA1c [<xref ref-type="bibr" rid="scirp.94524-ref20">20</xref>] . Liu et al. studied the effect of cinnamon along with chromium and carnosine in pre-diabetic patients for 4 months, which revealed a significant reduction in FPG levels [<xref ref-type="bibr" rid="scirp.94524-ref26">26</xref>] . There was no significant effect on HbA1c, as was demonstrated in a similar meta-analysis on a pre-diabetic population [<xref ref-type="bibr" rid="scirp.94524-ref26">26</xref>] .</p><p>Even though some studies have demonstrated that cinnamon plays a role in lowering blood sugar, others have reported the contrary. Studies done by Vanschoonbeek et al., and Blevin et al. did not show significant effect of cinnamon on FPG or HbA1c [<xref ref-type="bibr" rid="scirp.94524-ref6">6</xref>] . In a study done by Talaei et al. the effect of 3 g of Cinnamon supplement for 8 weeks was studied in diabetic patients which did not show any significant effect on FPG, fasting insulin levels or HbA1c [<xref ref-type="bibr" rid="scirp.94524-ref27">27</xref>] . Another study by Steven et al. also did not demonstrate a decrease in FPG and HbA1c after using 1 g of cinnamon daily for three months [<xref ref-type="bibr" rid="scirp.94524-ref27">27</xref>] . The conflicting evidence of these studies can be based on factors such as sample size, duration of treatment, dosage form and formula, dose range, presence of conventional treatments, background of the patients including their lifestyle and diet regimen, presence of confounding factors and the quality of study design [<xref ref-type="bibr" rid="scirp.94524-ref20">20</xref>] [<xref ref-type="bibr" rid="scirp.94524-ref26">26</xref>] [<xref ref-type="bibr" rid="scirp.94524-ref27">27</xref>] .</p></sec><sec id="s4"><title>4. Tea</title><p>In this section, we will uncover the background of herbal teas, specifically the Camellia Sinensis leaf tea which is commonly used in Oolong tea. Camellia Sinensis leaves are commonly used in teas in India, China and Taiwan among others. Black tea, Oolong tea and Green tea all come from the Camellia Sinensis leaf but have different fermentation processes [<xref ref-type="bibr" rid="scirp.94524-ref28">28</xref>] . Black tea is fully fermented, while Oolong tea is partially fermented. One of the main components is the amount of Catechins which are believed to influence glucose metabolism [<xref ref-type="bibr" rid="scirp.94524-ref28">28</xref>] . The amounts of catechins vary per tea type, but Green tea has the most (at 30% - 40% per cup) and Black tea has the least (3% - 10% per cup).</p><p>But how do these teas help lower sugar levels? According to Anderson and Polansky (2002) the Camellia Sinensis tea helps lower blood sugar by inducing insulin release [<xref ref-type="bibr" rid="scirp.94524-ref29">29</xref>] . Like sulfonylureas, it acts on the pancreas to release insulin thereby decreasing glucose in the bloodstream. Another possible mechanism of Camellia Sinensis tea is the catechin molecule that inhibits alpha-amylase, intestinal sucrase and alpha-glucosidase, all of which are involved in digestion of carbohydrates [<xref ref-type="bibr" rid="scirp.94524-ref28">28</xref>] . Another proposed mechanism is the increased expression of GLUT-4 transporter, which enhances glucose uptake by cells [<xref ref-type="bibr" rid="scirp.94524-ref30">30</xref>] . Lastly, the mechanism proposed by S. Khulood is Epigallocatechin Gallate (ECGC), found in Green tea, which are found to protect the beta-islet cells against cytokine damage [<xref ref-type="bibr" rid="scirp.94524-ref31">31</xref>] .</p><p>Regardless of the mechanism, the majority of research studies and articles written about the Camellia Sinensis tea have shown that it provides relative improvement in glucose levels. While the efficacy may vary between each experiment, the general trend demonstrates that Camellia Sinensis tea helps reduce blood glucose levels. In a study, by Wu et al., fructose-only fed rats were examined by their levels of fasting glucose, insulin, blood pressure, GLUT-4, and insulin-stimulated glucose uptake. These rats were found to have elevated levels of FBG, insulin, and blood pressure while GLUT-4 and insulin-stimulated glucose uptake were decreased. However, when the rats were given Fructose/Green tea combination, an improvement in all of these biomarkers was found [<xref ref-type="bibr" rid="scirp.94524-ref30">30</xref>] .</p><p>In another major study, 1898 subjects were used to compare the FBG levels in subjects consuming Green tea versus placebo/water [<xref ref-type="bibr" rid="scirp.94524-ref32">32</xref>] . This study showed a slight decrease in fasting blood glucose, which is regarded as significant improvement due to the large study population. Some of the studies may have shown improvement; however, studies with small sample sizes warrant further research to help establish more concrete results. For example, in a study by Nani et al., there were only 67 subjects that were evaluated for their research [<xref ref-type="bibr" rid="scirp.94524-ref33">33</xref>] . This study resulted in an average HbA1c decrease of 1.1%. Furthermore, there was an average decrease of 1.37 mmol/L and 1.22 mmol/L in FBG at 8 and 12 weeks respectively. Although this may be considered significant, the low sample sizes warrant the need for further studies to be conducted on a greater scale.</p></sec><sec id="s5"><title>5. Discussion</title><p>The prevalence of diabetes mellitus is high and rising worldwide due to the global increase in obesity and unhealthy lifestyles [<xref ref-type="bibr" rid="scirp.94524-ref9">9</xref>] . Type 2 diabetes accounts for more than 90% of diabetic cases and is associated with metabolic disorders of lipids and carbohydrates. Effective glycemic control in diabetic patients, including blood glucose levels and HbA1c, is essential to reduce the risks of microvascular and macrovascular complications. These complications include cardiovascular disease, diabetic retinopathy, nephropathy, neuropathy, and fatty liver disease [<xref ref-type="bibr" rid="scirp.94524-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.94524-ref8">8</xref>] . In fact, diabetes is the leading cause of renal failure and the most preventable cause of blindness in the United States [<xref ref-type="bibr" rid="scirp.94524-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.94524-ref20">20</xref>] . Therefore, treatment of diabetes is imperative. Efforts have been made to create a wide range of medical treatment for diabetes including the use of Metformin, sulfonylureas, SGLT-2 inhibitors, DPP-4 Inhibitors and injectable insulin. However, the side effects of presently available hypoglycemic agents have led to continuous efforts to explore other effective agents for the management of diabetes.</p><p>CAM with anti-hyperglycemic effects is gaining increased popularity among diabetic patients. Herbal medicines with strong anti-inflammatory and hypoglycemic properties routinely generate attention for a possible role in the management of diabetes mellitus. Current scientific research shows that consumption of ginger may have a favorable impact on glycemic indices in patients with diabetes. One study found that consumption of ginger extract, either raw or cooked, reduced FBG to normal levels as effectively as treatment with anti-diabetic medication [<xref ref-type="bibr" rid="scirp.94524-ref34">34</xref>] . Another study showed that the consumption of 500 mg/kg of polyphenol ginger extracts for 28 days reduced FBG in STZ-treated diabetic rats [<xref ref-type="bibr" rid="scirp.94524-ref35">35</xref>] . In a double-blind placebo-controlled clinical trial, patients with DM2 received either placebo or 2000 mg of ginger supplements per day for 10 weeks. Serum levels of FBG, total cholesterol, triacylglycerol, LDL-C, HDL-C, and HbA1c were analyzed. Ginger consumption significantly reduced serum levels of FBG and HbA1c in ginger-treated subjects compared to the placebo group [<xref ref-type="bibr" rid="scirp.94524-ref36">36</xref>] . In another clinical trial, diabetic patients were analyzed for changes in inflammatory markers, glycemic indices, and lipid profile after 12 weeks of supplementation with ginger. Improvements were most noticeable in glycemic indices and lowering of triglycerides with data supporting possible anti-inflammatory effects. Both HbA1c and insulin levels decreased, suggesting ginger may decrease insulin resistance and decrease serum glucose levels [<xref ref-type="bibr" rid="scirp.94524-ref37">37</xref>] .</p><p>The heterogeneity among studies exploring the effects of cinnamon on glycemic control makes it difficult to draw a valid conclusion. Priyanga et al. demonstrated that CZ improved the metabolism of glucose after a standard oral glucose load in rats. This was attributed to its ability to enhance insulin signaling thereby increasing glucose uptake by cells [<xref ref-type="bibr" rid="scirp.94524-ref38">38</xref>] . Similar results reported by Qin et al. and other studies have indicated the increased phosphorylation of IR [<xref ref-type="bibr" rid="scirp.94524-ref38">38</xref>] . A study done by Crawford et al. resulted in reduction of HbA1c in patients receiving 1 g of cinnamon daily [<xref ref-type="bibr" rid="scirp.94524-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.94524-ref27">27</xref>] . In a random clinical trial by Anderson et al., a significant reduction in FPG as well as a 2-hr glucose load was found [<xref ref-type="bibr" rid="scirp.94524-ref6">6</xref>] . Per Costello, out of the five meta-analyses done on the effect of cinnamon on hyperglycemia, only three reported significant decrease in FPG and one in HbA1c [<xref ref-type="bibr" rid="scirp.94524-ref20">20</xref>] . While using cinnamon in some of these studies has shown benefit in lowering blood sugar levels, others have failed to replicate such results. Therefore, the NCCIH, ADA, and Canadian diabetes association (CDA) do not advocate for or support the use of cinnamon as an anti-diabetic therapy due to lack of sufficient evidence [<xref ref-type="bibr" rid="scirp.94524-ref20">20</xref>] [<xref ref-type="bibr" rid="scirp.94524-ref26">26</xref>] .</p><p>Review of the literature regarding Camellia Sinensis tea consumption and its effect on glucose metabolism yield varying results. However, the majority of studies demonstrate lower blood glucose levels with the Camellia Sinensis tea. This is also demonstrated graphically in <xref ref-type="fig" rid="fig1">Figure 1</xref> of the paper by Kondo et al. [<xref ref-type="bibr" rid="scirp.94524-ref32">32</xref>] . Per Maruyama et al. Green tea will help lower FBG, but only when consumed at</p><p>higher concentrations [<xref ref-type="bibr" rid="scirp.94524-ref39">39</xref>] . In other studies, Green tea extract was found to lower FBG in diabetic patients with poor glycemic control [<xref ref-type="bibr" rid="scirp.94524-ref40">40</xref>] . However, a study by Yu et al., showed no difference between the use of Green tea, Green tea extract and placebo for HbA1c, fasting insulin and FBG [<xref ref-type="bibr" rid="scirp.94524-ref41">41</xref>] . Despite the number of studies conducted thus far, more research with greater sample sizes is required to find better evidence for the use of Camellia Sinensis tea in treating hyperglycemia.</p><p>Finally, complementary and alternative medicine can play a role in treating different conditions including diabetes. For example, Metformin, the first-line treatment drug fordiabetes, has its origins from a plant called Galegaofficinalis (French Lilac or Goat’s Rue) [<xref ref-type="bibr" rid="scirp.94524-ref5">5</xref>] . It is possible that some of the CAM used today could have the potential to become therapeutic treatments for diabetes in the future. Even though CAM has the potential to benefit an array of illnesses, it is important to remember that there are limitations to these products. The lack of physician-patient communication with regard to the use of CAM products as well as the possible drug-drug interactions are some of those limitations [<xref ref-type="bibr" rid="scirp.94524-ref2">2</xref>] . Therefore, further research with improved design quality is recommended to better understand the role of complementary and alternative medicine in the treatment of diabetes.</p></sec><sec id="s6"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest regarding the publication of this paper.</p></sec><sec id="s7"><title>Cite this paper</title><p>Atta, M., Jafari, S. and Moore, K. (2019) Complementary and Alternative Medicine: A Review on the Effects of Ginger, Cinnamon and Camellia Sinensis Leaf Tea in Diabetes. Journal of Diabetes Mellitus, 9, 126-136. https://doi.org/10.4236/jdm.2019.93012</p></sec><sec id="s8"><title>Abbreviation List</title></sec></body><back><ref-list><title>References</title><ref id="scirp.94524-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Diabetes. Who.int. https://www.who.int/news-room/fact-sheets/detail/diabetes</mixed-citation></ref><ref id="scirp.94524-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Kesavadev, J., Saboo, B., Sadikot, S., et al. (2016) Unproven Therapies for Diabetes and Their Implications. Advances in Therapy, 34, 60-77.  
https://doi.org/10.1007/s12325-016-0439-x</mixed-citation></ref><ref id="scirp.94524-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">American Diabetes Association (2016) Diagnosing Diabetes and Learning about Prediabetes. http://www.diabetes.org/diabetes-basics/diagnosis/?loc=db-slabnav</mixed-citation></ref><ref id="scirp.94524-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Loren, D., Roscoe, R. and Shack, A. (2018) Complementary and Alternative Medicine for Diabetes. Canadian Journal of Diabetes, 42, 154-161.  
https://doi.org/10.1016/j.jcjd.2017.10.023</mixed-citation></ref><ref id="scirp.94524-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Medagama, A. and Bandara, R. (2014) The Use of Complementary and Alternative Medicines (CAMs) in the Treatment of Diabetes Mellitus: Is Continued Use Safe and Effective? Nutrition Journal, 13, 102. https://doi.org/10.1186/1475-2891-13-102</mixed-citation></ref><ref id="scirp.94524-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Medagama, A. (2015) The Glycaemic Outcomes of Cinnamon, a Review of the Experimental Evidence and Clinical Trials. Nutrition Journal, 14, 108.  
https://doi.org/10.1186/s12937-015-0098-9</mixed-citation></ref><ref id="scirp.94524-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Johns Hopkins Medicine Complementary and Alternative Medicine.  
https://www.hopkinsmedicine.org/healthlibrary/conditions/complementary_and_alternative_medicine/home_page-complementary_and_alternative_medicine_85,P00185</mixed-citation></ref><ref id="scirp.94524-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Li, Y., Tran, V.H., Duke, C.C. and Roufogalis, B.D. (2012) Preventive and Protective Properties of Zingiber officinale (Ginger) in Diabetes Mellitus, Diabetic Complications, and Associated Lipid and Other Metabolic Disorders: A Brief Review. Evidence-Based Complementary and Alternative Medicine, 2012, Article ID: 516870.  
https://doi.org/10.1155/2012/516870</mixed-citation></ref><ref id="scirp.94524-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Daily, J.W., Yang, M. and Kim, S.S. (2015) Efficacy of Ginger for Treating Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. Journal of Ethnic Foods, 2, 36-43. https://doi.org/10.1016/j.jef.2015.02.007</mixed-citation></ref><ref id="scirp.94524-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Akash, M.S.H., Rehman, K., Tariq, M. and Chen, S. (2015) Zingiber officinale and Type 2 Diabetes Mellitus: Evidence from Experimental Studies. Critical Reviews in Eukaryotic Gene Expression, 25, 91-112.  
https://doi.org/10.1615/CritRevEukaryotGeneExpr.2015013358</mixed-citation></ref><ref id="scirp.94524-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Shanmugam, K.R., et al. (2011) Neuroprotective Effect of Ginger on Antioxidant Enzymes in Streptozotocin-Induced Diabetic Rats. Food and Chemical Toxicology, 49, 893-897. https://doi.org/10.1016/j.fct.2010.12.013</mixed-citation></ref><ref id="scirp.94524-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Kota, N., Panpatil, V.V., Kaleb, R., Varanasi, B. and Polasa, K. (2012) Dose Dependent Effect in the Inhibition of Oxidative Stress and Anti Clastogenic Potential of Ginger in STZ Induced Diabetic Rats. Food Chemistry, 135, 2954-2959.  
https://doi.org/10.1016/j.foodchem.2012.06.116</mixed-citation></ref><ref id="scirp.94524-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Ghlissi, Z., Atheymen, R., Boujbiha, M.A., Sahnoun, Z., MakniAyedi, F., Zeghal, K., El Feki, A. and Hakim, A. (2013) Antioxidant and Androgenic Effects of Dietary Ginger on Reproductive Function of Male Diabetic Rats. International Journal of Food Sciences and Nutrition, 64, 974-978.  
https://doi.org/10.3109/09637486.2013.812618</mixed-citation></ref><ref id="scirp.94524-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Shanmugam, K.R., Mal-likarjuna, K., Nishanth, K., Kuo, C.H. and Reddy, K.S. (2011) Protective Effect of Dietary Ginger on Antioxidant Enzymes and Oxidative Damage in Experimental Diabetic Rat Tissues. Food Chemistry, 124, 1436-1442.  
https://doi.org/10.1016/j.foodchem.2010.07.104</mixed-citation></ref><ref id="scirp.94524-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Henriksen, E.J. (2006) Exercise Training and the Antioxidant Alpha-Lipoic Acid in the Treatment of Insulin Resistance and Type 2 Diabetes. Free Radical Biology &amp; Medicine, 40, 3-12. https://doi.org/10.1016/j.freeradbiomed.2005.04.002</mixed-citation></ref><ref id="scirp.94524-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Mahluji, S., et al. (2013) Effects of Ginger (Zingiber officinale) on Plasma Glucose Level, HbA1c and Insulin Sensitivity in Type 2 Diabetic Patients. International Journal of Food Sciences and Nutrition, 64, 682-686.  
https://doi.org/10.3109/09637486.2013.775223</mixed-citation></ref><ref id="scirp.94524-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Isa, Y., Miyakawa, Y., Yanagisawa, M., Goto, T., Kang, M.S., Kawada, T., Morimitsu, Y., Kubota, K. and Tsuda, T. (2008) 6-Shogaol and 6-Gingerol, the Pungent of Ginger, Inhibit TNF-alpha Mediated Downregulation of Adiponectin Expression via Different Mechanisms in 3T3-L1 Adipocytes. Biochemical and Biophysical Research Communications, 373, 429-434. https://doi.org/10.1016/j.bbrc.2008.06.046</mixed-citation></ref><ref id="scirp.94524-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Abdulrazaq, N.B., Cho, M.M., Win, N.N., et al. (2011) Beneficial Effects of Ginger (Zingiber officinale) on Carbohydrate Metabolism in Streptozotocin-Induced Diabetic Rats. British Journal of Nutrition, 108, 1194-1201.  
https://doi.org/10.1017/S0007114511006635</mixed-citation></ref><ref id="scirp.94524-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Al-Amin, Z.M., Thomson, M., Al-Qattan, K.K., et al. (2006) Antidiabetic and Hypolipidemic Properties of Ginger (Zingiber officinale) in Streptozotocin-Induced Diabetic Rats. British Journal of Nutrition, 96, 660-666.  
https://doi.org/10.1079/BJN20061849</mixed-citation></ref><ref id="scirp.94524-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Costello, R., Dwyer, J., Saldanha, L., Bailey, R., Merkel, J. and Wambogo, E. (2016) Do Cinnamon Supplements Have a Role in Glycemic Control in Type 2 Diabetes? A Narrative Review. Journal of the Academy of Nutrition and Dietetics, 116, 1794-1802. https://doi.org/10.1016/j.jand.2016.07.015</mixed-citation></ref><ref id="scirp.94524-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Ranasinghe, P., Pigera, S., Premakumara, G., Galappaththy, P., Constantine, G. and Katulanda, P. (2013) Medicinal Properties of “True” Cinnamon (Cinnamomum zeylanicum). A Systematic Review. BMC Complementary and Alternative Medicine, 13, 275. https://doi.org/10.1186/1472-6882-13-275</mixed-citation></ref><ref id="scirp.94524-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Taher, M., Abdul Majid, F. and Sarmidi, M. (2006) A Proanthocyanidin from Cinnamomum Zeylanicum Stimulates Phosphorylation of Insulin Receptor in 3T3-L1 Adipocytes. Jurnal Teknologi, 44, 53-68. https://doi.org/10.11113/jt.v44.385</mixed-citation></ref><ref id="scirp.94524-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Visweswara, P. and Hua Gan, S. (2014) Cinnamon: A Multifaceted Medicinal Plant. Evidenced-Based Complementary and Alternative Medicine, 2014, Article ID: 642942. https://doi.org/10.1155/2014/642942</mixed-citation></ref><ref id="scirp.94524-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">Markey, O., McClean, C., Medlow, P., et al. (2011) Effect of Cinnamon on Gastric Emptying, Arterial Stiffness, Postprandial Lipemia, Glycemia, and Appetite Responses to High-Fat Breakfast. Cardiovascular Diabetology, 10, 78.  
https://doi.org/10.1186/1475-2840-10-78</mixed-citation></ref><ref id="scirp.94524-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">Nikzamir, A., Palangi, A., Kheirollaha, A., et al. (2014) Expression of Glucose Transporter 4 (GLUT4) Is Increased by Cinnamaldehyde in C2C12 Mouse Muscle Cells. Iranian Red Crescent Medical Journal, 16, e134264.  
https://doi.org/10.5812/ircmj.13426</mixed-citation></ref><ref id="scirp.94524-ref26"><label>26</label><mixed-citation publication-type="other" xlink:type="simple">Liu, Y., Cotillard, A., Vatier, C., et al. (2015) A Dietary Supplement Containing Cinnamon, Chromium and Carnosine Decreases Fasting Plasma Glucose and Increases Lean Mass in Overweight or Obese Pre-Diabetic Subjects: A Randomized, Placebo-Controlled Trial. PLoS ONE, 10, e0138646.  
https://doi.org/10.1371/journal.pone.0138646</mixed-citation></ref><ref id="scirp.94524-ref27"><label>27</label><mixed-citation publication-type="other" xlink:type="simple">Talaei, B., Amouzegar, A., Sahranavard, S., Hedayati, M., Mirmiran, P. and Azizi, F. (2017) Effects of Cinnamon Consumption on Glycemic Indicators, Advanced Glycation End Products, and Antioxidant Status in Type 2 Diabetic Patients. Nutrients, 9, 991. https://doi.org/10.3390/nu9090991</mixed-citation></ref><ref id="scirp.94524-ref28"><label>28</label><mixed-citation publication-type="other" xlink:type="simple">Stote, K. and Baer, D. (2008) Tea Consumption May Improve Biomarkers of Insulin Sensitivity and Risk Factors for Diabetes. The Journal of Nutrition, 138, 1584S-1588S.  
https://doi.org/10.1093/jn/138.8.1584S</mixed-citation></ref><ref id="scirp.94524-ref29"><label>29</label><mixed-citation publication-type="other" xlink:type="simple">Anderson, R. and Polansky, M. (2002) Tea Enhances Insulin Activity. Journal of Agricultural and Food Chemistry, 50, 7182-7186. https://doi.org/10.1021/jf020514c</mixed-citation></ref><ref id="scirp.94524-ref30"><label>30</label><mixed-citation publication-type="other" xlink:type="simple">Wu, L., Juan, C., Hwang, L., Hsu, Y., Ho, P. and Ho, L. (2004) Green Tea Supplementation Ameliorates Insulin Resistance and Increases Glucose Transporter IV Content in a Fructose-Fed Rat Model. European Journal of Nutrition, 43, 116-124.  
https://doi.org/10.1007/s00394-004-0450-x</mixed-citation></ref><ref id="scirp.94524-ref31"><label>31</label><mixed-citation publication-type="other" xlink:type="simple">Khulood, S.S. (2014) Hypoglycemic Property of Ginger and Green Tea and Their Possible Mechanisms in Diabetes Mellitus. The Open Conference Proceedings Journal, 5, 13-19. https://doi.org/10.2174/2210289201405010013</mixed-citation></ref><ref id="scirp.94524-ref32"><label>32</label><mixed-citation publication-type="other" xlink:type="simple">Kondo, Y., Goto, A., Noma, H., Iso, H., Hayashi, K. and Noda, M. (2018) Effects of Coffee and Tea Consumption on Glucose Metabolism: A Systematic Review and Network Meta-Analysis. Nutrients, 11, 48. https://doi.org/10.3390/nu11010048</mixed-citation></ref><ref id="scirp.94524-ref33"><label>33</label><mixed-citation publication-type="other" xlink:type="simple">Nani, D., SitiSuhaila, M., Faridah, M. and Wan Zahiruddin, W. (2016) The Effect of Gymnemasylvestre and Camellia sinensis on Patients with Type 2 Diabetes Mellitus. Health and the Environment Journal, 7, 1-19.</mixed-citation></ref><ref id="scirp.94524-ref34"><label>34</label><mixed-citation publication-type="other" xlink:type="simple">Oludoyin, A.P. and Adegoke, S.R. (2014) Efficacy of Ginger (Zingiber officinale Roscoe) Extracts in Lowering Blood Glucose in Normal and High Fat Diet-Induced Diabetic Rats. American Journal of Food and Nutrition, 2, 55-58.</mixed-citation></ref><ref id="scirp.94524-ref35"><label>35</label><mixed-citation publication-type="other" xlink:type="simple">Kazeem, M.I., Akanji, M.A., Yakubu, M.T. and Ashafa, A.O.T. (2013) Protective Effect of Free and Bound Polyphenol Extracts from Ginger (Zingiber officinale Roscoe) on the Hepatic Antioxidant and Some Carbohydrate Metabolizing Enzymes of Streptozotocin-Induced Diabetic Rats. Evidence-Based Complementary and Alternative Medicine, 2013, Article ID: 935486. https://doi.org/10.1155/2013/935486</mixed-citation></ref><ref id="scirp.94524-ref36"><label>36</label><mixed-citation publication-type="other" xlink:type="simple">Khandouzi, N., Shidfar, F., Rajab, A., Rahideh, T., Hosseini, P. and Mir Taheri, M. (2015) The Effects of Ginger on Fasting Blood Sugar, Hemoglobin a1c, Apolipoprotein B, Apolipoprotein a-I and Malondialdehyde in Type 2 Diabetic Patients. Iranian Journal of Pharmaceutical Research, 14, 131-140.</mixed-citation></ref><ref id="scirp.94524-ref37"><label>37</label><mixed-citation publication-type="other" xlink:type="simple">Haas, W. (2015) The Role of Ginger in Type 2 Diabetes Mellitus. Relias Media.  
https://www.reliasmedia.com/articles/135945-the-role-of-ginger-in-type-2-diabetes-mellitus</mixed-citation></ref><ref id="scirp.94524-ref38"><label>38</label><mixed-citation publication-type="other" xlink:type="simple">Ranasinghe, P., Gunatilake, M., Gunapala, N., et al. (2012) Effects of Cinnamomum zeylanicum (Ceylon cinnamon) on Blood Glucose and Lipids in a Diabetic and Healthy Rat Model. Pharmacognosy Research, 4, 73.  
https://doi.org/10.4103/0974-8490.94719</mixed-citation></ref><ref id="scirp.94524-ref39"><label>39</label><mixed-citation publication-type="other" xlink:type="simple">Maruyama, K., Iso, H., Sasaki, S. and Fukino, Y. (2009) The Association between Concentrations of Green Tea and Blood Glucose Levels. Journal of Clinical Biochemistry and Nutrition, 44, 41-45. https://doi.org/10.3164/jcbn.08-13</mixed-citation></ref><ref id="scirp.94524-ref40"><label>40</label><mixed-citation publication-type="other" xlink:type="simple">Khan, F., Irshad, G., Hafiz, S. and Bari, M. (2012) Effect of Green Tea Polyphenols on HbA1C in Type 2 Diabetic Patients. Medical Forum Monthly, 23, 48-50.</mixed-citation></ref><ref id="scirp.94524-ref41"><label>41</label><mixed-citation publication-type="other" xlink:type="simple">Yu, J., Song, P., Perry, R., Penfold, C. and Cooper, A. (2017) The Effectiveness of Green Tea or Green Tea Extract on Insulin Resistance and Glycemic Control in Type 2 Diabetes Mellitus: A Meta-Analysis. Diabetes &amp; Metabolism Journal, 41, 251. https://doi.org/10.4093/dmj.2017.41.4.251</mixed-citation></ref></ref-list></back></article>